News Releases

  • Email
  • Print
  • Share
  • Text
Highlight Glossary Terms

News tagged ‘ChildhoodCancer’ clear

  • When the eye cancer retinoblastoma is diagnosed in racial and ethnic minority children whose families don't have private health insurance, it often takes a more invasive course than in other children, probably because of delays in diagnosis, according to researchers at Dana-Farber/Children's Hospital Cancer Center in Boston.

Tags: ChildhoodCancer, Disparities

  • Almost two-thirds of children who receive stem cell transplants are readmitted to the hospital within six months, according to researchers at Dana-Farber/Children’s Hospital Cancer Center in Boston.

Tags: ChildhoodCancer, StemCellTransplant

  • An irregularity within many neuroblastoma cells may indicate whether the tumor is vulnerable to a new class of anti-cancer drugs known as BET bromodomain inhibitors.

Tags: ChildhoodCancer

  • Dana-Farber/Children's Hospital Cancer Center is one of the first three institutions to be named as a Center of Excellence by Alex's Lemonade Stand Foundation.

Tags: ChildhoodCancer, Grants, Honors

  • Stuart H. Orkin, MD, chairman of the department of pediatric oncology at Dana-Farber/Children’s Hospital Cancer Center, will receive the Jessie Stevenson Kovalenko Medal at the National Academy of Sciences’ 150th Annual meeting in April.

Tags: ChildhoodCancer, Honors

  • A national drug shortage has been linked to a higher rate of relapse among Hodgkin lymphoma patients enrolled in a national pediatric clinical trial, report researchers involved in the study.

Tags: chemotherapy, ChildhoodCancer, Lymphoma

  • Pediatric patients with B-precursor acute lymphoblastic leukemia who are likely to relapse after chemotherapy treatment can reduce those odds by receiving additional courses of chemotherapy, according to research by Dana-Farber/Children's Hospital Cancer Center investigators.

Tags: chemotherapy, ChildhoodCancer, Leukemia

  • Dana-Farber/Children's Hospital Cancer Center physicians and nurses are collaborating to create an Egypt-based fellowship training program in pediatric oncology.

Tags: ChildhoodCancer, Partnerships

  • Dana-Farber/Children's Hospital Cancer Center researchers have linked genetic mutations to each of the four recognized subtypes of medulloblastoma, the most common malignant brain tumor of children.

Tags: BasicResearch, ChildhoodCancer, Genomics, BrainTumors

  • The American Association for Cancer Research named Alan D. D'Andrea, MD, the recipient of the 52nd Annual AACR G.H.A. Clowes Memorial Award for his work in understanding cancer survival and progression.

Tags: BasicResearch, ChildhoodCancer, Honors

Showing 11-20 of 38 items